Global (United States, European Union and China) Pet Pain Management Drugs Market Research Report 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 113

Report ID: 292684

In 2019, the market size of Pet Pain Management Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pet Pain Management Drugs.

This report studies the global market size of Pet Pain Management Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pet Pain Management Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Boehringer Ingelheim
Zoetis
Merck Animal Health
Bayer
Vetoquinol
Norbrook Laboratories
Ceva Sante Animale
Dechra Pharmaceuticals
Chanelle

Market Segment by Product Type
NSAIDs
Opioids
Local Anesthetics
Alpha-2 Agonists
Disease-modifying Osteoarthritis Agents
Other Drugs

Market Segment by Application
Dogs
Cats
Horses
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Pet Pain Management Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pet Pain Management Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Pet Pain Management Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Pet Pain Management Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 NSAIDs
1.3.3 Opioids
1.3.4 Local Anesthetics
1.3.5 Alpha-2 Agonists
1.3.6 Disease-modifying Osteoarthritis Agents
1.3.7 Other Drugs
1.4 Market Segment by Application
1.4.1 Global Pet Pain Management Drugs Market Share by Application (2019-2025)
1.4.2 Dogs
1.4.3 Cats
1.4.4 Horses
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Pet Pain Management Drugs Market Size
2.1.1 Global Pet Pain Management Drugs Revenue 2014-2025
2.1.2 Global Pet Pain Management Drugs Sales 2014-2025
2.2 Pet Pain Management Drugs Growth Rate by Regions
2.2.1 Global Pet Pain Management Drugs Sales by Regions 2014-2019
2.2.2 Global Pet Pain Management Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Pet Pain Management Drugs Sales by Manufacturers
3.1.1 Pet Pain Management Drugs Sales by Manufacturers 2014-2019
3.1.2 Pet Pain Management Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Pet Pain Management Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Pet Pain Management Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Pet Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Pet Pain Management Drugs Price by Manufacturers
3.4 Key Manufacturers Pet Pain Management Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Pet Pain Management Drugs Market
3.6 Key Manufacturers Pet Pain Management Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 NSAIDs Sales and Revenue (2014-2019)
4.1.2 Opioids Sales and Revenue (2014-2019)
4.1.3 Local Anesthetics Sales and Revenue (2014-2019)
4.1.4 Alpha-2 Agonists Sales and Revenue (2014-2019)
4.1.5 Disease-modifying Osteoarthritis Agents Sales and Revenue (2014-2019)
4.1.6 Other Drugs Sales and Revenue (2014-2019)
4.2 Global Pet Pain Management Drugs Sales Market Share by Type
4.3 Global Pet Pain Management Drugs Revenue Market Share by Type
4.4 Pet Pain Management Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Pet Pain Management Drugs Sales by Application

6 United States
6.1 United States Pet Pain Management Drugs Breakdown Data by Company
6.2 United States Pet Pain Management Drugs Breakdown Data by Type
6.3 United States Pet Pain Management Drugs Breakdown Data by Application

7 European Union
7.1 European Union Pet Pain Management Drugs Breakdown Data by Company
7.2 European Union Pet Pain Management Drugs Breakdown Data by Type
7.3 European Union Pet Pain Management Drugs Breakdown Data by Application

8 China
8.1 China Pet Pain Management Drugs Breakdown Data by Company
8.2 China Pet Pain Management Drugs Breakdown Data by Type
8.3 China Pet Pain Management Drugs Breakdown Data by Application

9 Rest of World
9.1 Rest of World Pet Pain Management Drugs Breakdown Data by Company
9.2 Rest of World Pet Pain Management Drugs Breakdown Data by Type
9.3 Rest of World Pet Pain Management Drugs Breakdown Data by Application
9.4 Rest of World Pet Pain Management Drugs Breakdown Data by Countries
9.4.1 Rest of World Pet Pain Management Drugs Sales by Countries
9.4.2 Rest of World Pet Pain Management Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.1.4 Pet Pain Management Drugs Product Introduction
10.1.5 Boehringer Ingelheim Recent Development
10.2 Zoetis
10.2.1 Zoetis Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.2.4 Pet Pain Management Drugs Product Introduction
10.2.5 Zoetis Recent Development
10.3 Merck Animal Health
10.3.1 Merck Animal Health Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.3.4 Pet Pain Management Drugs Product Introduction
10.3.5 Merck Animal Health Recent Development
10.4 Bayer
10.4.1 Bayer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.4.4 Pet Pain Management Drugs Product Introduction
10.4.5 Bayer Recent Development
10.5 Vetoquinol
10.5.1 Vetoquinol Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.5.4 Pet Pain Management Drugs Product Introduction
10.5.5 Vetoquinol Recent Development
10.6 Norbrook Laboratories
10.6.1 Norbrook Laboratories Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.6.4 Pet Pain Management Drugs Product Introduction
10.6.5 Norbrook Laboratories Recent Development
10.7 Ceva Sante Animale
10.7.1 Ceva Sante Animale Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.7.4 Pet Pain Management Drugs Product Introduction
10.7.5 Ceva Sante Animale Recent Development
10.8 Dechra Pharmaceuticals
10.8.1 Dechra Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.8.4 Pet Pain Management Drugs Product Introduction
10.8.5 Dechra Pharmaceuticals Recent Development
10.9 Chanelle
10.9.1 Chanelle Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Pet Pain Management Drugs
10.9.4 Pet Pain Management Drugs Product Introduction
10.9.5 Chanelle Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Pet Pain Management Drugs Sales Channels
11.2.2 Pet Pain Management Drugs Distributors
11.3 Pet Pain Management Drugs Customers

12 Market Forecast
12.1 Global Pet Pain Management Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Pet Pain Management Drugs Sales Forecast by Type
12.3 Global Pet Pain Management Drugs Sales Forecast by Application
12.4 Pet Pain Management Drugs Forecast by Regions
12.4.1 Global Pet Pain Management Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Pet Pain Management Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer